THE ECONOMICS AND COST-EFFECTIVENESS OF CRITICAL CARE MEDICINE

被引:109
作者
CHALFIN, DB
COHEN, IL
LAMBRINOS, J
机构
[1] BUFFALO GEN HOSP,SURG INTENS CARE UNIT,BUFFALO,NY 14203
[2] UNION COLL,GRAD MANAGEMENT INST,SCHENECTADY,NY 12308
关键词
D O I
10.1007/BF01712339
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:952 / 961
页数:10
相关论文
共 64 条
[31]   COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH STREPTOKINASE IN ELDERLY PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION [J].
KRUMHOLZ, HM ;
PASTERNAK, RC ;
WEINSTEIN, MC ;
FRIESINGER, GC ;
RIDKER, PM ;
TOSTESON, ANA ;
GOLDMAN, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (01) :7-13
[32]   A COST-EFFECTIVENESS MODEL FOR CORONARY THROMBOLYSIS REPERFUSION THERAPY [J].
LAFFEL, GL ;
FINEBERG, HV ;
BRAUNWALD, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (05) :B79-B90
[33]  
LAMBRINOS J, 1987, MANAGING CRITICAL CA, P358
[34]  
LEAF A, 1989, NEW ENGL J MED, V321, P890
[35]  
LEE PR, 1992, WESTERN J MED, V157, P576
[36]   MORTALITY PROBABILITY-MODELS (MPM-II) BASED ON AN INTERNATIONAL COHORT OF INTENSIVE-CARE UNIT PATIENTS [J].
LEMESHOW, S ;
TERES, D ;
KLAR, J ;
AVRUNIN, JS ;
GEHLBACH, SH ;
RAPOPORT, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2478-2486
[37]   COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR AS COMPARED WITH STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION [J].
MARK, DB ;
HLATKY, MA ;
CALIFF, RM ;
NAYLOR, CD ;
LEE, KL ;
ARMSTRONG, PW ;
BARBASH, G ;
WHITE, H ;
SIMOONS, ML ;
NELSON, CL ;
CLAPPCHANNING, N ;
KNIGHT, JD ;
HARRELL, FE ;
SIMES, J ;
TOPOL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21) :1418-1424
[38]  
MIRANDA DR, 1992, PRINCIPLES CRITICAL, V2, P2300
[39]   OUTCOME ASSESSMENT IN CARDIOVASCULAR COST-BENEFIT STUDIES [J].
OBRIEN, B ;
RUSHBY, J .
AMERICAN HEART JOURNAL, 1990, 119 (03) :740-748
[40]   PATTERNS OF RESOURCE CONSUMPTION IN MEDICAL INTENSIVE-CARE [J].
OYE, RK ;
BELLAMY, PE .
CHEST, 1991, 99 (03) :685-689